Every record from Nordanalyt · page 5
The slowest and most precise contributor. The only lab here offering ion-pair, SEC and ICP-MS as routine. Measured offset against the reference laboratory is -0.005 pp on 357 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041788 | TB-500 | FGP | FGP-2601-T1617 | 2026-Q1 | 99.93 | 3.95 | 95.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041593 | Retatrutide | QSC | QSC-2510-H7626 | 2026-Q1 | 97.73 | 4.17 | 94.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043190 | Exenatide | GL Biochem | GLBI-2509-A8203 | 2026-Q1 | 98.38 | 3.85 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042829 | BPC-157 | GGPeps | GGPE-2512-N1746 | 2026-Q1 | 99.45 | 6.84 | 99.3 | Supplier-supplied | 0 | PASS |
| AX-2026-042973 | Retatrutide | KP | KP-2511-K4263 | 2026-Q1 | 97.08 | 3.64 | 105.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043361 | BPC-157 | CPC | CPC-2510-R2456 | 2026-Q1 | 98.03 | 8.30 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2026-042948 | Ipamorelin | KP | KP-2512-X4190 | 2026-Q1 | 98.55 | 2.68 | — | Laboratory-retained | 2 | FAIL |
| AX-2026-042250 | Melanotan II | Homopeptide | HOMO-2511-M1199 | 2026-Q1 | 99.06 | 4.02 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2026-041899 | BPC-157 | JEEP | JEEP-2509-G3860 | 2026-Q1 | 99.77 | 4.04 | 90.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042052 | Tirzepatide | TFC | TFC-2508-L6746 | 2026-Q1 | 98.48 | 2.02 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041751 | Selank | FGP | FGP-2511-D1094 | 2026-Q1 | 99.93 | 6.14 | 89.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043208 | GHRP-6 | SGN | SGN-2510-P9566 | 2026-Q1 | 99.02 | 2.08 | 99.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042007 | Epitalon | TFC | TFC-2508-W5644 | 2026-Q1 | 98.55 | 6.16 | 102.0 | Supplier-supplied | 0 | FAIL |
| AX-2026-042993 | Tirzepatide | KP | KP-2506-B4700 | 2025-Q4 | 98.16 | 4.39 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042876 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2509-T2530 | 2026-Q1 | 99.48 | 3.82 | 98.1 | Supplier-supplied | 1 | FAIL |
| AX-2026-042710 | Melanotan II | GGPeps | GGPE-2509-H8939 | 2026-Q1 | 98.47 | 5.20 | 96.4 | Buyer-sourced | 1 | FAIL |
| AX-2026-042149 | Melanotan II | Homopeptide | HOMO-2505-N9201 | 2025-Q4 | 98.49 | 2.54 | 101.4 | Supplier-supplied | 1 | FAIL |
| AX-2026-042332 | L-Glutathione (reduced) | HJ | HJ-2507-P3062 | 2025-Q4 | 99.06 | 7.02 | 106.0 | Supplier-supplied | 0 | PASS |
| AX-2026-041277 | Tirzepatide | WWB | WWB-2506-T2732 | 2025-Q4 | 98.72 | 4.05 | 107.3 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-043012 | BPC-157 | KP | KP-2511-M5346 | 2025-Q4 | 98.33 | 5.04 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042714 | Retatrutide | GGPeps | GGPE-2511-W9618 | 2026-Q1 | 98.19 | 5.80 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041603 | Tirzepatide | QSC | QSC-2511-S7989 | 2025-Q4 | 99.28 | 4.21 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042264 | GHRP-6 | Homopeptide | HOMO-2505-A1799 | 2025-Q4 | 99.93 | 3.36 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042082 | Semaglutide | TFC | TFC-2507-K7301 | 2025-Q4 | 98.81 | 3.99 | 93.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043132 | Retatrutide | SSA | SSA-2510-E6502 | 2025-Q4 | 97.37 | 4.05 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041276 | Semaglutide | WWB | WWB-2507-V2845 | 2025-Q4 | 99.01 | 4.27 | 105.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042151 | GHRP-2 | Homopeptide | HOMO-2505-T8504 | 2025-Q4 | 99.91 | 4.64 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043329 | GHRP-6 | CPC | CPC-2507-G2066 | 2025-Q4 | 99.81 | 6.74 | 102.0 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042408 | L-Glutathione (reduced) | SWB | SWB-2506-B5296 | 2025-Q4 | 98.70 | 10.06 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020383 | MK-677 (Ibutamoren mesylate) | MKM | MKM-2505-X3641 | 2025-Q4 | 99.66 | 2.55 | 92.7 | Supplier-supplied | 2 | FAIL |
| AX-2025-018756 | TB-500 | QSC | QSC-2505-C7889 | 2025-Q4 | 99.13 | 3.70 | 91.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020452 | KPV | KP | KP-2509-N5148 | 2025-Q4 | 98.69 | 2.22 | 101.9 | Buyer-sourced | 2 | FAIL |
| AX-2025-019969 | BPC-157 | SWB | SWB-2511-N6092 | 2025-Q4 | 98.62 | 6.42 | 89.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018732 | GHRP-6 | QSC | QSC-2511-K7380 | 2025-Q4 | 99.88 | 6.69 | 106.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018587 | ARA-290 | QYB | QYB-2511-Y5015 | 2025-Q4 | 99.83 | 5.24 | 90.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021258 | Cagrilintide | BCH | BCH-2509-A6666 | 2025-Q4 | 99.19 | 5.44 | 105.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020275 | 5-Amino-1MQ | MKM | MKM-2506-T2989 | 2025-Q4 | 98.68 | 6.58 | 93.5 | Supplier-supplied | 1 | FAIL |
| AX-2025-019528 | Leuprolide | Homopeptide | HOMO-2509-X1081 | 2025-Q4 | 99.16 | 5.58 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020777 | Tirzepatide | SGN | SGN-2505-G9671 | 2025-Q4 | 99.19 | 5.14 | 90.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020080 | Semaglutide | ERP | ERP-2509-A8587 | 2025-Q4 | 98.20 | 5.65 | 91.9 | Supplier-supplied | 1 | MARGINAL |